Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Harris

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safetyS K Kelley, L A Harris, D Xie, et al.
Journal of Clinical Microbiology|June 1, 1990
Purification, characterization, and localization of a protein antigen shared by thermophilic campylobactersJ D Dubreuil, M Kostrzynska, S M Logan, et al.
American Journal of Mental Deficiency|September 1, 1982
Learning, memory, and transfer in profoundly, severely, and moderately mentally retarded personsN R Ellis, J R Deacon, L A Harris, et al.
Alimentary Pharmacology & Therapeutics|September 16, 2009
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scaleB Spiegel, R Bolus, L A Harris, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2010
Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practiceB M R Spiegel, R Bolus, L A Harris, et al.
The American Journal of Gastroenterology|July 25, 2012
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challengeDaniel A Leffler, C P Kelly, H Z Abdallah, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2010
Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trialsB M R Spiegel, R Bolus, N Agarwal, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safetyS K Kelley, L A Harris, D Xie, et al.
Journal of Clinical Microbiology|June 1, 1990
Purification, characterization, and localization of a protein antigen shared by thermophilic campylobactersJ D Dubreuil, M Kostrzynska, S M Logan, et al.
American Journal of Mental Deficiency|September 1, 1982
Learning, memory, and transfer in profoundly, severely, and moderately mentally retarded personsN R Ellis, J R Deacon, L A Harris, et al.
Alimentary Pharmacology & Therapeutics|September 16, 2009
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scaleB Spiegel, R Bolus, L A Harris, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2010
Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practiceB M R Spiegel, R Bolus, L A Harris, et al.
The American Journal of Gastroenterology|July 25, 2012
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challengeDaniel A Leffler, C P Kelly, H Z Abdallah, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2010
Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trialsB M R Spiegel, R Bolus, N Agarwal, et al.
Pageof 3